Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib with Trastuzumab in HER2-positive Metastatic Breast Cancer
NCT02448420Phase 2Completed
- Sponsor
- SOLTI
- Start
- Jul 2015
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by SOLTI. Started Jul 2015; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02448420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448420.